Plumbagin inhibits CYP2J/EETs metabolic pathway and leads to heart injury in cardiac organoids and rats

This publication has 35 references indexed in Scilit:

• Development of human embryonic stem cell-derived cardiomyocytes and application of fluorescence probe substrate for characterization of cytochrome P450 enzyme 2J2
  Drug Metabolism and Disposition, 2025
• Astaxanthin ameliorated isoproterenol induced myocardial infarction via improving the mitochondrial function and antioxidant activity in rats
  Journal of Biochemical and Molecular Toxicology, 2024
• Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats
  Biochemical Pharmacology, 2024
• A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative Mechanisms
  Cardiovascular Drugs and Therapy, 2024
• Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative Stress, preventing inflammation and apoptosis: Ultrastructural and computational approaches
  Heliyon, 2024
• Assessment of doxorubicin toxicity using human cardiac organoids: A novel model for evaluating drug cardiotoxicity
  Chemico-Biological Interactions, 2023
• Site-directed deuteration of dronedarone preserves cytochrome P4502J2 activity and mitigates its cardiac adverse effects in canine arrhythmic hearts
  Acta Pharmaceutica Sinica B, 2022
• Plumbagin induces testicular damage via mitochondrial-dependent cell death
  Chemico-Biological Interactions, 2021
• Plumbagin protects the myocardial damage by modulating the cardiac biomarkers, antioxidants, and apoptosis signaling in the doxorubicin‐induced cardiotoxicity in rats
  Environmental Toxicology, 2020
• Inhibition and inactivation of human CYP2J2: Implications in cardiac pathophysiology and opportunities in cancer therapy
  Biochemical Pharmacology, 2017